Attovia Therapeutics Files Amended Charter and Bylaws After IPO

What Happened
On August 6, 2026, Attovia Therapeutics, Inc. (Attovia) filed an 8-K reporting that it has filed an Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws with the Delaware Secretary of State. These governance documents became effective in connection with the closing of the company’s initial public offering (IPO). The changes were approved previously by the board and stockholders and are described in the company’s final prospectus dated August 4, 2026.

Key Details

• Effective date: August 6, 2026 (tied to the closing of the IPO).
• Documents amended: Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws.
• IPO disclosure: Description of capital stock and related provisions appear in the Prospectus dated August 4, 2026 (Registration Statement on Form S-1, File No. 333-297452).
• Corporate form note: Attovia’s common stock par value is $0.0001 per share; the charter and bylaws are filed with the SEC and incorporated by reference.

Why It Matters
The amended charter and bylaws define Attovia’s corporate governance and the rights and obligations of its shareholders now that the company has completed its IPO. Investors should review the Prospectus section titled “Description of Capital Stock” and the filed charter/bylaws to understand voting rights, equity structure, and other governance provisions that affect shareholder rights and protections.